Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex

The identification of protein-protein interaction disruptors (PPIDs) that disrupt the YAP/TAZ-TEAD interaction has gained considerable momentum. Several studies have shown that YAP/TAZ are no longer oncogenic when their interaction with the TEAD family of transcription factors is disrupted. The tran...

Full description

Bibliographic Details
Main Authors: Ajaybabu V. Pobbati, Brian P. Rubin
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/24/6001
_version_ 1797544254817435648
author Ajaybabu V. Pobbati
Brian P. Rubin
author_facet Ajaybabu V. Pobbati
Brian P. Rubin
author_sort Ajaybabu V. Pobbati
collection DOAJ
description The identification of protein-protein interaction disruptors (PPIDs) that disrupt the YAP/TAZ-TEAD interaction has gained considerable momentum. Several studies have shown that YAP/TAZ are no longer oncogenic when their interaction with the TEAD family of transcription factors is disrupted. The transcriptional co-regulator YAP (its homolog TAZ) interact with the surface pockets of TEADs. Peptidomimetic modalities like cystine-dense peptides and YAP cyclic and linear peptides exploit surface pockets (interface 2 and interface 3) on TEADs and function as PPIDs. The TEAD surface might pose a challenge for generating an effective small molecule PPID. Interestingly, TEADs also have a central pocket that is distinct from the surface pockets, and which small molecules leverage exclusively to disrupt the YAP/TAZ-TEAD interaction (allosteric PPIDs). Although small molecules that occupy the central pocket belong to diverse classes, they display certain common features. They are flexible, which allows them to adopt a palmitate-like conformation, and they have a predominant hydrophobic portion that contacts several hydrophobic residues and a small hydrophilic portion that faces the central pocket opening. Despite such progress, more selective PPIDs that also display favorable pharmacokinetic properties and show tolerable toxicity profiles are required to evaluate the feasibility of using these PPIDs for cancer therapy.
first_indexed 2024-03-10T13:56:58Z
format Article
id doaj.art-3ebaf70674fd45b781d076e327fb3536
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T13:56:58Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-3ebaf70674fd45b781d076e327fb35362023-11-21T01:28:26ZengMDPI AGMolecules1420-30492020-12-012524600110.3390/molecules25246001Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional ComplexAjaybabu V. Pobbati0Brian P. Rubin1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USADepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USAThe identification of protein-protein interaction disruptors (PPIDs) that disrupt the YAP/TAZ-TEAD interaction has gained considerable momentum. Several studies have shown that YAP/TAZ are no longer oncogenic when their interaction with the TEAD family of transcription factors is disrupted. The transcriptional co-regulator YAP (its homolog TAZ) interact with the surface pockets of TEADs. Peptidomimetic modalities like cystine-dense peptides and YAP cyclic and linear peptides exploit surface pockets (interface 2 and interface 3) on TEADs and function as PPIDs. The TEAD surface might pose a challenge for generating an effective small molecule PPID. Interestingly, TEADs also have a central pocket that is distinct from the surface pockets, and which small molecules leverage exclusively to disrupt the YAP/TAZ-TEAD interaction (allosteric PPIDs). Although small molecules that occupy the central pocket belong to diverse classes, they display certain common features. They are flexible, which allows them to adopt a palmitate-like conformation, and they have a predominant hydrophobic portion that contacts several hydrophobic residues and a small hydrophilic portion that faces the central pocket opening. Despite such progress, more selective PPIDs that also display favorable pharmacokinetic properties and show tolerable toxicity profiles are required to evaluate the feasibility of using these PPIDs for cancer therapy.https://www.mdpi.com/1420-3049/25/24/6001TEADYAPTAZprotein-protein interaction disruptorsPPIDHippo pathway
spellingShingle Ajaybabu V. Pobbati
Brian P. Rubin
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
Molecules
TEAD
YAP
TAZ
protein-protein interaction disruptors
PPID
Hippo pathway
title Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
title_full Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
title_fullStr Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
title_full_unstemmed Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
title_short Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
title_sort protein protein interaction disruptors of the yap taz tead transcriptional complex
topic TEAD
YAP
TAZ
protein-protein interaction disruptors
PPID
Hippo pathway
url https://www.mdpi.com/1420-3049/25/24/6001
work_keys_str_mv AT ajaybabuvpobbati proteinproteininteractiondisruptorsoftheyaptazteadtranscriptionalcomplex
AT brianprubin proteinproteininteractiondisruptorsoftheyaptazteadtranscriptionalcomplex